Hisamitsu Pharmaceutical Co., Inc. (TYO:4530)

TYO:4530 Revenue

In the fiscal year ending February 28, 2026, Hisamitsu Pharmaceutical Co. had annual revenue of 163.02B JPY with 4.50% growth. Hisamitsu Pharmaceutical Co. had revenue of 48.51B in the quarter ending February 28, 2026, with 8.39% growth.

• Revenue: 163.02B
• Revenue Growth: +4.50%
• P/S Ratio: 2.61
• Revenue / Employee: 58.24M
• Employees: 2,799
• Market Cap: 425.23B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Medicine and Related Product Business 152.65B 97.9%
• Others 3.35B 2.1%

By Geography

Chart

• Japan 82.36B 52.8%
• United States of America 38.90B 24.9%
• Others 34.75B 22.3%

Fiscal year ended Feb 28, 2025 See the full TYO:4530 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Feb 28, 2026	163.02B	7.02B	4.50%
Feb 28, 2025	156.01B	14.30B	10.09%
Feb 29, 2024	141.71B	13.38B	10.42%
Feb 28, 2023	128.33B	8.14B	6.77%
Feb 28, 2022	120.19B	5.68B	4.96%

Data Source: S&P Global Market Intelligence Last updated: Apr 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 30, 2026

Data Sources Report a data error